BCL-2-interacting mediator of cell death (Bim) is a novel biomarker for response to anti-PD-1 therapy in patients with advanced melanoma
| Image |  |
|---|---|
| Description | scientific article published on 27 October 2016 |
| Author/s |
author: Sean S. Park Roxana S. Dronca |
| Publication date | October 27, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |